Temporal Changes in Tracheal Aspirate Pathogens, Resistance Patterns, and Inflammatory Biomarkers in Critically Ill Patients: An Exploratory Retrospective Cohort Study
Abstract
Objective: Nosocomial and ventilator-associated pneumonia are major causes of morbidity and mortality in intensive care units (ICUs). Although tracheal aspirate cultures (TACs) are routinely obtained, temporal changes in antimicrobial resistance and systemic inflammation within the same patient remain poorly characterized. This study evaluated microbiological and laboratory changes using serial TAC samples.
Methods: This retrospective cohort study included adult ICU patients admitted to a tertiary center between January 2022 and July 2025 who underwent at least two TACs and had complete laboratory data. Changes in pathogen distribution, antimicrobial resistance patterns, and inflammatory biomarkers between sequential TAC episodes were analyzed.
Results: Forty-six patients were included, with an overall mortality rate of 97.8%. The median interval between TACs was 13.5 days. Pathogen distribution shifted toward Klebsiella spp. in the second TAC. Extensively drug-resistant isolates increased from 23.9% to 58.7%. Resistance to ceftazidime and methicillin also increased, whereas the proportion of isolates without resistance decreased. Laboratory findings demonstrated persistent physiological stress, including elevated C-reactive protein, reduced albumin, increased blood urea nitrogen/creatinine ratio, and declining blood cell counts.
Conclusion: Critically ill patients receiving prolonged mechanical ventilation demonstrated temporal changes in pathogen distribution, antimicrobial resistance patterns, and inflammatory biomarkers over approximately two weeks. These findings suggest ongoing microbiological and inflammatory alterations during extended ICU stays. Larger prospective studies are needed to determine the clinical significance of these longitudinal changes.
Keywords
Intensive care unit, Ventilator-associated pneumonia, Tracheal aspirate culture, Antimicrobial resistance, Extensively drug-resistant organisms, Inflammatory biomarkers
Ethical Statement
References
- Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18(2):208. doi:10.1186/cc13775.
- Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61-111. doi:10.1093/cid/ciw353.
- Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017;50(3):1700582. doi:10.1183/13993003.00582-2017.
- Magill SS, O’Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, et al. Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):1732-44. doi:10.1056/NEJMoa1801550.
- Fois AG, Paliogiannis P, Scano V, Cau S, Babudieri S, Perra R, et al. The systemic inflammation index on admission predicts in-hospital mortality in COVID-19 patients. Molecules. 2020;25(23):5725. doi:10.3390/molecules25235725.
- Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen H, et al. A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy. Cancer. 2016;122(14):2158-67. doi:10.1002/cncr.30057.
- Yang R, Chang Q, Meng X, Gao N, Wang W. Prognostic value of systemic immune-inflammation index in cancer: a meta-analysis. J Cancer. 2018;9(18):3295-302. doi:10.7150/jca.25691.
- Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, et al. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal. 2019;33(8):e22964. doi:10.1002/jcla.22964.
- Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81. doi:10.1111/j.1469-0691.2011.03570.x.
- Baran B, Yetkin NA, Rabahoğlu B, Tutar N, Gülmez İ. Assessment of mortality risk in patients with community-acquired pneumonia: role of novel inflammatory biomarkers. J Clin Lab Anal. 2025;39(17):e70081. doi:10.1002/jcla.70081.